Free Shipping for orders over $50 in the United States

The Perfect Drop Pin™️Earrings
The Perfect Drop Pin™️Earrings
The Perfect Drop Pin™️Earrings

The Perfect Drop Pin™️Earrings

Regular price
Sale price
Tax included.
Quantity must be 1 or more

Do you know that in 2017 940,000 people died of AIDS and AIDS-related illnesses?😢

Help us to promote HIV and AIDS public health issue awareness by wearing our FREE Perfect Drop Pin™️Earrings.😍

🌎 Just pay for shipping 

December 1st is World AIDS Day.  Fashion For All Women™️ will be donating a portion of all proceeds to the UNAIDS association to sustain HIV prevention and treatment.  

  • Fine or Fashion: Fashion
  • Material: Zinc Alloy
  • Style: Bohemia
  • Texture Of Material: Metal
  • Modeling: Geometric Type
  • Treatment Process: Electroplate
  • Colour: Gold, Silver

HIV and AIDS facts (from UNAIDS data 2018):

HIV continues to be a major global public health issue. In 2017 an estimated 36.9 million people were living with HIV (including 1.8 million children) – with a global HIV prevalence of 0.8% among adults. Around 25% of these same people do not know that they have the virus.

Since the start of the epidemic, an estimated 77.3 million people have been infected with HIV and 35.4 million people have died of AIDS and AIDS-related illnesses. 

The vast majority of people living with HIV are located in low- and middle- income countries, with an estimated 66% living in sub-Saharan Africa. Among this group 19.6 million are living in East and Southern Africa which saw 800,000 new HIV infections in 2017. 

There is renewed concern that the annual number of new infections among adults has remained static in recent years. In 2017, there were roughly 1.8 million new HIV infections – the same as in 2016. 

Global new HIV infections have declined by just 18% in the past seven years, from 2.2 million in 2010 to 1.8 million in 2017. Although this is nearly half the number of new infections compared to the peak in 1996 (3.4 million), the decline is not quick enough to reach the target of fewer than 500,000 by 2020. 

While new HIV infections among children globally have also declined, from 270,000 in 2010 to 180,000 in 2017 (35%), reports indicate that this is far less progress being made than previously thought and there is much more that needs to be done to improve knowledge of HIV and HIV testing among adolescents and young adults.

Young women are especially at risk, with around 7,000 new infections each week among young people aged 15-24 occurring among this group. In sub-Saharan Africa, three in four new infections are among girls aged 15–19 years and young women aged 15–24 years are twice as likely to be living with HIV than men.

More than one third (35%) of women around the world have experienced physical and/or sexual violence at some time in their lives. In some regions, women who experience violence are one and a half times more likely to become infected with HIV.

Young women are especially at risk, with around 7,000 new infections each week among young people aged 15-24 occurring among this groupNew HIV infections are rising in around 50 countries. In Eastern Europe and Central Asia, the annual number of new HIV infections has doubled, and new HIV infections have increased by more than a quarter in the Middle East and North Africa over the past 20 years.

Despite the progress made across the countries which have witnessed a decline in new infections, progress in combating viral transmission is still not happening fast enough to meet global targets.

Despite challenges, new global efforts have meant that the number of people receiving HIV treatment has increased dramatically in recent years, particularly in resource-poor countries.  

In 2017, 59% of all people living with HIV were accessing treatment. Of those, 47% were virally suppressed. 21.7 million people living with HIV were receiving antiretroviral treatment – an increase of 2.3 million since 2016 and up from 8 million in 2010. However, this level of treatment scale-up is still not enough for the world to meet its global target of 30 million people on treatment by 2020.